(Q33932312)

30 July 2017

1 reference

title

Esophageal varices. I. Clinical presentation, medical therapy, and endoscopic therapy (English)

1 reference

30 July 2017

Luketic VA

1

1 reference

30 July 2017

Sanyal AJ

series ordinal

2

1 reference

30 July 2017

publication date

1 June 2000

1 reference

Gastroenterology Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

29

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

337-385

1 reference

A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Frequent endoscopic variceal sclerotherapy increases risk of complications. Prospective randomized controlled study of two treatment schedules.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Balloon tamponade technique and efficacy in variceal haemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Somatostatin: an alternative to sclerotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol and haemodynamic response in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Splanchnic hemodynamics in chronic portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prediction of variceal hemorrhage by esophageal endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Sclerotherapy with or without octreotide for acute variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Changes in splanchnic blood flow in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Isosorbide dinitrate in experimental portal hypertension: a study of factors that modulate the hemodynamic response.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

1 reference

7 January 2021

Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic ultrasonography classification of gastric varices in patients with cirrhosis. Comparison with endoscopic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect of propranolol on hepatic blood flow in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Octreotide in variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

The veins of the oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Value of Endoscopic Ultrasonography in the Management of Portal Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Relationship among beta-adrenergic blockade, propranolol concentration, and liver function in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Duplex-Doppler ultrasonography in the evaluation of cirrhotic patients with portal hypertension and in the analysis of their response to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child class B and C) cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prognostic factors in upper G.I. bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Treatment of bleeding oesophageal varices: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A prospective evaluation of the endoscopic spectrum of overtube-related esophageal mucosal injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect of propranolol on portosystemic collateral circulation in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Portal hemodynamics during nitroglycerin administration in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Portal pressure, presence of gastroesophageal varices and variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic esophageal variceal band ligation: how intensively should we ligate?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A hepatologist's view of variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Pathophysiology of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Somatostatin in acute bleeding oesophageal varices. Pharmacology and rationale for use

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Meta-analysis of value of propranolol in prevention of variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect and mechanism of action of isosorbide-5-mononitrate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Oesophageal perforation following endoscopic variceal ligation and balloon tamponade

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect of intraportal nitroglycerin on portosystemic hemodynamics in patients with cirrhosis: comparison with i.v. route

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Relationship between dose, blood level and haemodynamic response in patients with cirrhosis receiving propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Complications associated with endoscopic band ligation of esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Risk factors for hemorrhage from gastric fundal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hyposensitivity to vasopressin in a hemorrhaged-transfused rat model of portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal Bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic injection sclerotherapy vs. endoscopic variceal ligation in arresting acute variceal bleeding for patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Reduction in early recurrence of variceal bleeding by propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect of vasodilators on hepatic microcirculation: a study of the inhibition of norepinephrine-induced vasoconstriction in the isolated perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A study of octreotide in oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Changes in blood flow, portal pressure and shunting during the development of cirrhosis in response to beta-blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: evidence for an impaired cardiopulmonary baroreflex function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Pharmacokinetics of long acting propranolol. Implications for therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A pilot study on modified endoscopic variceal ligation using endoscopic ultrasonography with color Doppler function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Plasma endothelin-1 levels of children with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Life-threatening hemorrhage of the digestive tract in cirrhotic patients. An assessment of the postoperative mortality after emergency portacaval shunt

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Efficacy of oral propranolol and injection sclerotherapy in the long-term management of variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

1 reference

7 January 2021

Somatostatin (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

The Saeed Six-Shooter: a prospective study of a new endoscopic multiple rubber-band ligator for the treatment of varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: a multicenter prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Ito cell contraction in response to endothelin-1 and substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic techniques and complications in variceal sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic sclerotherapy for esophago-gastric varices: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Clinical pharmacology of active variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Drug therapy: Propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic esophageal varix ligation: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Octreotide infusion or emergency sclerotherapy for variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Controlled trial of vasopressin plus nitroglycerin vs. vasopressin alone in the treatment of bleeding esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Lack of vasopressin action on splanchnic hemodynamics during bleeding: a study in conscious, portal hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Isosorbide dinitrate in portal hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Stereoselective delivery and actions of beta receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Controlled clinical trial of injection sclerotherapy for active variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970119-9

7 January 2021

10.1016/S0889-8553(05)70119-9

Identifiers

DOI

1 reference

30 July 2017

1 reference